Anal Microbial Patterns and Oncogenic Human Papillomavirus in a Pilot Study of Nigerian Men Who Have Sex with Men at Risk for or Living with HIV.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 15 9 2018
medline: 27 2 2020
entrez: 15 9 2018
Statut: ppublish

Résumé

To cluster anal microbiota and define microbial patterns associated with biological, clinical, and behavioral correlates among Nigerian men who have sex with men (MSM) living with or at risk for HIV. In this cross-sectional pilot study, the 15 most abundant 16S taxa in the anal microbiota of 113 MSM underwent unsupervised K-means clustering and z-score comparisons to define similarities and dissimilarities among 4 microbiota taxonomic profiles. Distributions of oncogenic HPV (high-risk human papillomavirus [HR-HPV]), concurrent HIV, antiretroviral therapy (ART), and other clinical and behavioral data were evaluated using Fisher's exact and Kruskal-Wallis tests to determine biological signatures of cluster membership. Prevotella was consistently represented in each cluster, but the average composition ranged from 14% to 44%. Cluster 2 was enriched with a member of the Fusobacteria phylum, Sneathia (29%). More participants of cluster 2 were HIV infected and taking ART (83%, 5/6), were virally suppressed (80%, 4/5), had HPV-16 (66.7%, 4/6), and reported no vaginal sex partners (83%, 5/6). HPV-35, a highly prevalent oncogenic HPV in Nigeria, was observed in all clusters except cluster 2 (0%, 0/6). Other covariates were similar across clusters (all p > .05). K-means unsupervised clustering, a canonical pattern recognition method, generalized the microbial community composition and structure while accounting for among sample variability. Further studies are needed to evaluate whether an anal microbial community enriched with members of the Fusobacteria phylum is associated with HIV-infected MSM who are virally suppressed and have a concurrent HPV-16.

Identifiants

pubmed: 30215262
doi: 10.1089/AID.2018.0158
pmc: PMC6434585
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-275

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH099001
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA134274
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010051
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH110358
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA225403
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120913
Pays : United States
Organisme : PEPFAR
Pays : United States

Investigateurs

Manhattan Charurat (M)
Julie Ake (J)
Sylvia Adebajo (S)
Stefan Baral (S)
Erik Billings (E)
Trevor Crowell (T)
George Eluwa (G)
Abiola Fasina (A)
Charlotte Gaydos (C)
Sosthenes Ketende (S)
Afoke Kokogho (A)
Hongjie Liu (H)
Jennifer Malia (J)
Olumide Makanjuola (O)
Nelson Michael (N)
Nicaise Ndembi (N)
Jean Njab (J)
Rebecca Nowak (R)
Oluwasolape Olawore (O)
Zahra Parker (Z)
Sheila Peel (S)
Habib Ramadhani (H)
Merlin Robb (M)
Cristina Rodriguez-Hart (C)
Eric Sanders-Buell (E)
Sodsai Tovanabutra (S)

Références

AIDS. 2017 Mar 27;31(6):857-862
pubmed: 28118207
PLoS One. 2013 May 22;8(5):e63514
pubmed: 23717441
Microbiome. 2013 Oct 12;1(1):26
pubmed: 24451087
PLoS Comput Biol. 2012;8(7):e1002606
pubmed: 22807668
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Lancet Infect Dis. 2018 Feb;18(2):198-206
pubmed: 29158102
Sci Rep. 2015 Nov 17;5:16865
pubmed: 26574055
Curr Opin HIV AIDS. 2016 Mar;11(2):182-90
pubmed: 26679414
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1249-56
pubmed: 21494911
BMC Genomics. 2012;13 Suppl 8:S4
pubmed: 23281612
Lancet HIV. 2017 Oct;4(10):e449-e456
pubmed: 28732773
Mucosal Immunol. 2017 Jul;10(4):996-1007
pubmed: 27848950
J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
Eur J Gynaecol Oncol. 2010;31(4):425-8
pubmed: 20882886
AIDS. 2017 Feb 20;31(4):591-594
pubmed: 27922858
Sci Transl Med. 2012 May 2;4(132):132ra52
pubmed: 22553250
Anaerobe. 2013 Dec;24:117-20
pubmed: 23548695
Infect Immun. 2000 Jun;68(6):3140-6
pubmed: 10816455
AIDS Res Hum Retroviruses. 2018 Mar;34(3):277-281
pubmed: 29308654
Sex Transm Dis. 2016 Apr;43(4):243-8
pubmed: 26967301
Immunol Lett. 2014 Dec;162(2 Pt A):54-61
pubmed: 24972311
EBioMedicine. 2016 Jan 28;5:135-46
pubmed: 27077120
Gut. 2016 May;65(5):749-56
pubmed: 26719299
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
PLoS Pathog. 2014 Feb 20;10(2):e1003829
pubmed: 24586144
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
Anaerobe. 2011 Aug;17(4):191-5
pubmed: 21376827
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
Gut Microbes. 2014 Jul 1;5(4):562-70
pubmed: 25078714
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
BMC Infect Dis. 2016 Jun 14;16:293
pubmed: 27301867
Mucosal Immunol. 2015 Sep;8(5):1009-20
pubmed: 25586559
J Clin Microbiol. 2009 Jan;47(1):38-47
pubmed: 18971361
Science. 2017 Jun 2;356(6341):938-945
pubmed: 28572388
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S114-23
pubmed: 25723975
Sex Transm Dis. 2013 Dec;40(12):944-9
pubmed: 24220356
J Clin Invest. 2011 Dec;121(12):4593-9
pubmed: 22133884
PLoS One. 2016 Apr 26;11(4):e0153274
pubmed: 27115350
AIDS. 2014 Mar 13;28(5):753-60
pubmed: 24335481
PLoS One. 2015 May 05;10(5):e0125363
pubmed: 25942472
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038128
Virology. 2013 Oct;445(1-2):232-43
pubmed: 23998342
AIDS. 2017 Mar 27;31(6):863-865
pubmed: 28272137
Infect Agent Cancer. 2010 Oct 20;5:19
pubmed: 20961432
mSystems. 2017 Jan 17;2(1):
pubmed: 28144630
Infect Immun. 2000 Apr;68(4):1893-8
pubmed: 10722579
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S107-13
pubmed: 25723974
Viruses. 2018 Mar 10;10(3):
pubmed: 29534424
Bioinformatics. 2011 Aug 15;27(16):2194-200
pubmed: 21700674
BMC Bioinformatics. 2015 May 17;16:164
pubmed: 25980407
AIDS. 2015 Nov 28;29(18):2409-18
pubmed: 26355675

Auteurs

Rebecca G Nowak (RG)

1 Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland.

Søren M Bentzen (SM)

2 University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
3 Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.

Jacques Ravel (J)

4 Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland.

Trevor A Crowell (TA)

5 U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland.
6 Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.

Wuese Dauda (W)

7 Institute of Human Virology Nigeria, Abuja, Nigeria.

Bing Ma (B)

4 Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland.

Hongjie Liu (H)

8 Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, Maryland.

William A Blattner (WA)

1 Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland.

Stefan D Baral (SD)

9 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Man E Charurat (ME)

1 Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH